2022. Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. SKIN The Journal of Cutaneous Medicine. 6, 2 (Mar. 2022), 109–121. DOI:https://doi.org/10.25251/skin.6.2.4.